А.Аварзэд
Loading...
Товч нэр
А.Аварзэд
Бүтэн нэр
Амгаланбаатар Аварзэд
Латин нэр
Amgalanbaatar Avarzed
Албан тушаал
Дарга
Гэрээт багш
Эрдмийн цол
Дэд профессор
Боловсролын зэрэг
Доктор (Ph.D)
ORCID
Scopus Author ID
11 results
Now showing 1 - 10 of 11
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Scopus© Citations 4 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Antibacterial activity of a novel synthetic progesterone species carrying a linoleic acid molecule against Helicobacter pylori and the hormonal effect of its steroid on a murine macrophage-like cell line(Elsevier BV, 2014-03); ;Shimomura, Hirofumi ;Hosoda, Kouichi ;Hayashi, ShunjiYokota, KenjiScopus© Citations 15 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, A novel role of catalase in cholesterol uptake of Helicobacter pylori(2023-03) ;Hosoda, Kouichi ;Wanibuchi, Kiyofumi; ;Shoji, MitsuruHayashi, ShunjiHelicobacter pylori infection is known to be a significant risk factor for the development of gastric cancers in humans. This pathogen exhibits unique biological characteristics in membrane lipid composition. Specifically, H. pylori incorporates exogenous cholesterol into biomembranes and uses cholesterol as the membrane lipid constituents. A previous study by our group demonstrated that phosphatidylethanolamine of H. pylori functions as the cholesterol-binding lipid. It is, however, unclear whether H. pylori is equipped with protein molecules involved in the cholesterol uptake. We, therefore, examined H. pylori proteins that tightly bind to cholesterol. As a consequence, H. pylori catalase (KatA) turned out to be a candidate of the cholesterol uptake-associated protein. In addition, an H. pylori mutant strain that expresses KatA protein lacking catalase activity was significantly lower in total cholesterol contents than the wild-type H. pylori strain. The putative amino acid sequence of KatA found out to contain a number of the cholesterol recognition/interaction amino acid consensus sequence domains (CRAC and CARC domains). These results suggest that H. pylori KatA with normal folding conformation acts as the cholesterol-binding or -storage protein.Scopus© Citations 6 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, A short review, effect of dimethyl-β-cyclodextrin on the interaction between Helicobacter pylori and steroidal compounds(2021-04) ;Wanibuchi, Kiyofumi ;Hosoda, Kouichi; ;Hirai, YoshikazuShoji, MitsuruThe 2,6-di-O-methyl-β-cyclodextrin (dMβCD) is an amphiphilic annular compound consisting of seven dimethyl-glucose molecules. This compound is well known as a solubilizer of lipophilic compounds. Especially, dMβCD extracts cholesterol from the plasma membrane of mammalian cells and releases the cholesterol to the aqueous solution. The experimental use of dMβCD, therefore, serves to investigate the role of cholesterol in the mammalian cell membrane. It is, however, unclear as to how dMβCD extracts cholesterol incorporated into the glycerophospholipid biomembrane. Meanwhile, dMβCD acts as a beneficial compound for Helicobacter pylori and is used as the standard component for supporting the growth of this bacterium in the serum-free culture. However, the detailed mechanism of dMβCD for supporting the growth of H. pylori is still to be clarified. H. pylori is a Gram-negative microaerophilic bacillus recognized as a pathogen concerned with gastrointestinal diseases in human. Previous studies by our group have successfully obtained the H. pylori strains culturable without dMβCD and demonstrated the distinct effects of dMβCD on the interaction between H. pylori and exogenous steroidal compounds. For instance, dMβCD promotes and inhibits the absorption of cholesterol and several steroidal compounds respectively into the biomembranes of H. pylori. In this study we summarized behaviors of dMβCD toward steroidal compounds relevant to H. pylori.Scopus© Citations 7 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Biomembranal Myristoyl-Phosphatidylcholine as a Potential Target of the Cell Injury Activity of Vitamin D Decomposition Products in Eukaryotic Cells(2025-08) ;Shimomura, Hirofumi ;Wanibuchi, Kiyofumi ;Hosoda, Kouich; Shoji, MitsuruBACKGROUND: Vitamin D decomposition products target a myristic acid sidechain of the predominant glycerophospholipid constructed in the biomembranes of Helicobacter pylori, causing gastric cancer in humans, and disrupt the membrane structure, followed by bacteriolysis. No earlier studies, however, elucidate whether vitamin D decomposition products interact with the glycerophospholipids that construct the eukaryotic biomembranes and confer whatever cell disorders. METHODS: A gastric cancer cell line, MKN45, and a non-cancer cell line, Vero, were used in this study. Cell injury activities of vitamin D decomposition products (VDP1 and VD2-1) and a VDP1 derivative (VD3-7) were examined by the 3-(4,5-di-methylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Identification of a glycerophospholipid was performed by 1H-nuclear magnetic resonance (NMR). Fatty acid composition and glycerophospholipid molecular species were analyzed by gas chromatography/mass spectrometry (GC/MS) and liquid chromatography/mass spectrometry (LC/MS), respectively. Structure collapse-induction activity of VDP1, VD2-1 and VD3-7 to glycerophospholipid vesicles was examined using the pigment-containing lamellar vesicles. RESULTS: MKN45 cells exhibited higher susceptibility to the cell injury activity of VDP1 and VD2-1 than Vero cells. In the analysis of biomembrane lipids, the glycerophospholipid phosphatidylcholine (PC) molecular species turned out to conspicuously differ between MKN45 cells and Vero cells. Contents of myristoyl-PC were higher in MKN45 cells than in Vero cells, while contents of oleoyl-PC were higher in Vero cells than in MKN45 cells. Meanwhile, the contents of palmitoyl- and palmitoleoyl-PC were almost equal between these cells. We next examined the structure collapse-induction activity of VDP1, VD2-1 and VD3-7 on the lamellar vesicles prepared with dimyristoyl-PC, dipalmitoyl-PC and dioleoyl-PC. The vitamin D decomposition products and a VDP1 derivative induced the structural collapse of dimyristoyl- and dipalmitoyl-PC lamellar vesicles but almost no structural collapse of dioleoyl-PC lamellar vesicles. These results suggest that the contents of myristoyl-PC in biomembranes are associated with the susceptibility of eukaryotic cells to the cell injury activity of VDP1, VD2-1 and VD3-7. In addition, no VD3-7 affected the viability of Vero cells and selectively decreased the viability of MKN45 cells. CONCLUSIONS: In the future, we will expect to be capable of developing novel antitumor agents targeting the myristic acid sidechain of biomembranal PC using a vitamin D decomposition product as the fundamental structure. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, The Chronic and Acute Toxicity of Traditional Medicines Containing Terminalia chebula(Korean Pharmacopuncture Institute, 2023-03) ;Arongqiqige; ;Song, Wang ;Xi, Wei ChengOBJECTIVES: Terminalia chebula, the main ingredient of Altan Arur 5, has been used for many years in traditional medicine. This medicine is more effective than other drugs and is used to treat chronic gastritis and gastrointestinal disorders such as peptic ulcers and esophageal reflux. Other ingredients of Altan Arur 5 are Punica granatum (pomegranate), tulip seeds, black balm, and excreta of Trogopterus xanthipes. The main ingredients of T. chebula are antibacterial and analgesic in traditional medicine. Despite having been used for many years and although many studies have been conducted on the beneficial effects of this medicine and its ingredients, the toxicity of Altan Arur 5 has not yet been elucidated. Therefore, we aimed to study the toxicity of Altan Arur 5 to ensure that it is safe to use. METHODS: Acute and chronic toxicity of Altan Arur 5 were assessed in 10 Kunming mice and 8 Sprague-Dawley rats, respectively, in different doses. In the acute toxicity study, Altan Arur 5 was orally administered to Kunming mice in doses of 12 g/kg, 24 g/kg, and 48 g/kg for 14 days. In the chronic toxicity study, it was orally administered to Sprague-Dawley rats in doses of 1.25 g/kg, 2.5 g/kg, and 5 g/kg for 12 weeks. RESULTS: No significant differences were observed in the relative organ weights for mice treated with Altan Arur 5 compared with those in the control group. Furthermore, no macro- or microstructural changes were noted in the organs of any group. CONCLUSION: Our toxicity testing revealed that the traditional medicine Altan Arur 5 has no toxic effects in vivo. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Unique responses of Helicobacter pylori to exogenous hydrophobic compounds(2020-07) ;Shimomura, Hirofumi ;Wanibuchi, Kiyofumi ;Hosoda, Kouichi; Masui, HisashiHelicobacter pylori is a pathogen responsible for peptic ulcers and gastric cancers in human. One of the unique biological features of this bacterium is a membrane lipid composition significantly differed from that of typical Gram-negative bacteria. Due to its unique lipid composition, the responses of H. pylori to various exogenous lipophilic compounds significantly differ from the responses of typical Gram-negative bacteria to the same lipophilic compounds. For instance, some steroidal compounds are incorporated into the biomembranes of H. pylori through the intermediation of the myristoyl-phosphatidylethanolamine (PE). In addition, H. pylori shows high susceptibility to bacteriolytic action of lipids such as 3-carbonyl steroids, vitamin D, and indene compounds. These lipids are also considered to interact with myristoyl-PE of H. pylori membranes, and to ultimately confer the bactericidal action to this bacterium. In this study we summarize the lipids concerned with H. pylori and suggest the possibility of the development of chemotherapeutic medicines that act on the membrane lipid component of H. pylori.Scopus© Citations 13 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Identification and characterization of a vitamin D3 decomposition product bactericidal against Helicobacter pylori(Springer Science and Business Media LLC, 2015-03-09) ;Hosoda, Kouichi ;Shimomura, Hirofumi ;Wanibuchi, Kiyofumi ;Masui, HisashiScopus© Citations 49 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Aspects for development of novel antibacterial medicines using a vitamin D3 decomposition product in Helicobacter pylori infection(2023-11) ;Wanibuchi, Kiyofumi ;Hosoda, Kouichi; ;Ihara, MasatoTakezawa, MotokiA previous study by our group demonstrated that a vitamin D3 decomposition product (VDP1) acts as the selective bactericidal substance on Helicobacter pylori. VDP1 is an indene compound modified with a carbonyl and an alkyl. The alkyl of VDP1 turned out to be a mandatory structure to exert effective bactericidal action on H. pylori. Meanwhile, it still remains to be clarified as to how influence the alteration of the carbonyl in VDP1 has on the anti-H. pylori activity. In this study, we synthesized novel VDP1 derivatives that replaced the carbonyl of VDP1 by various functional groups and investigated the antibacterial action of the VDP1 derivatives on H. pylori. VDP1 derivatives retaining either a hydroxy (VD3-1) or an acetic ester (VD3-3) exhibited more effective bactericidal action to H. pylori than VDP1. The replacement of the carbonyl of VDP1 by either an allyl acetate (VD3-2) or an acrylic acid (VD3-5) provided almost no change to the anti-H. pylori activity. Apart from this, an isomer of VDP1 (VD3-4) slightly improved anti-H. pylori activity of VDP1. Meanwhile, the replacement of the carbonyl of VDP1 by a methyl acrylate (VD3-6) attenuated the anti-H. pylori activity. As with VDP1, its derivatives also were suggested to exert the anti-H. pylori action through the interaction with myristic acid side chains of dimyristoyl-phosphatidylethanolamine, a characteristic membrane lipid constituent of this pathogen. These results indicate that it is capable of developing specific antibacterial medicines for H. pylori targeting the biomembranal dimyristoyl-phosphatidylethanolamine using VDP1 as the fundamental structure.Scopus© Citations 2 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, A short review: the biological activity of vitamin D and its decomposition products(2025-02) ;Shimomura, Hirofumi ;Wanibuchi, Kiyofumi ;Hosoda, Kouich; Shoji, MitsuruA vitamin D3 metabolite 1α,25-dihydroxyvitamin D3 exhibits numerous hormonal actions to various tissues and cells such as induction of calcium ion absorption, bone metabolism, activation of innate immune system. Because hormonal actions of 1α,25-dihydroxyvitamin D3 are too complex, it is difficult to better understand overall views of intermolecular networks on the cell activation by 1α,25-dihydroxyvitamin D3. In this review we concisely outline the most fundamental molecular mechanisms for the cell activation by 1α,25-dihydroxyvitamin D3 based on the previous and recent studies. In addition, we expound biological activity of 25-hydroxyvitamin D3 and 1α,25-dihydroxyvitamin D3 that differs from hormonal actions. In addition, recent studies by our group revealed that vitamin D decomposition products confer extremely selective bactericidal action to Helicobacter pylori, a pathogen causative gastritis, peptic ulcers and gastric cancers in human. Vitamin D decomposition products induce the bacteriolysis as targeting of characteristic glycerophospholipids composed of the bacterial biomembranes. In the future we will expect to be capable of developing novel antibacterial agents targeting a characteristic glycerophospholipid of the pathogenic bacteria using vitamin D decomposition products as fundamental structures.Scopus© Citations 3
